ARAF,BRAF和CRAF激酶的表征和抑制剂敏感性
Emre Tkacik1, Dong Man Jang2, Kayla Boxer3
1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA; Systems, Synthetic, and Quantitative Biology PhD Program, Harvard Medical School, Boston, Massachusetts, USA.
The Journal of biological chemistry
|October 10, 2025
概括
RAF 抑制剂在 ARAF,BRAF 和 CRAF 异型中表现出不同的有效性. II型抑制剂对CRAF有很强的作用,但对ARAF没有影响,影响了癌症治疗策略.
科学领域:
- 分子生物学分子生物学
- 生物化学 生物化学
- 在瘤学瘤学.
背景情况:
- RAS-RAF-MEK-ERK通路调节细胞生长;突变,特别是BRAF V600E,驱动诸如黑色素瘤之类的癌症.
- 在ARAF和CRAF中激活突变也在各种癌症中发现.
- 存在RAF抑制剂,但它们的异型特异性功效并没有得到很好的比较.
研究的目的:
- 系统地比较不同类型的RAF抑制剂与ARAF,BRAF和CRAF的强度.
- 了解差异性异构体抑制的生化基础.
- 为开发具有提高选择性的新型RAF抑制剂提供信息.
主要方法:
- 单体和二元ARAF,BRAF和CRAF激酶的生物化学表征.
- 对13种I型,I.5型和II型RAF抑制剂的功效测量.
- 对CRAF抑制剂复合物的晶体分析.
主要成果:
- 一种类型I抑制剂SB590885在RAF异型中显示出类似的强度.
- 类型I.5抑制剂对BRAF V600E最有效.
- II型抑制剂对CRAF有很强的作用,对ARAF的作用较小,对BRAF的作用中等,具有积极的合作性.
结论:
- 根据异型,RAF抑制剂的有效性因异型而异,挑战了II型药物的"泛RAF抑制剂"概念.
- 晶体结构显示出不同的结合模式和二元化接口.
- 这些发现指导了下一代RAF抑制剂的设计,其针对癌症治疗具有量身定制的异型选择性.
相关概念视频
01:07MAPK Signaling Cascades
7.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
01:22PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
01:20The JAK-STAT Signaling Pathway
12.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.0K
02:38The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K
01:25cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K